Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
2020; Mary Ann Liebert, Inc.; Volume: 18; Issue: 4 Linguagem: Inglês
10.1089/met.2020.0037
ISSN1557-8518
AutoresAnca Pantea Stoian, Yajnavalka Banerjee, Ali A. Rizvi, Manfredi Rizzo,
Tópico(s)COVID-19 and healthcare impacts
ResumoMetabolic Syndrome and Related DisordersVol. 18, No. 4 CommentaryDiabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future ManagementAnca Pantea Stoian, Yajnavalka Banerjee, Ali A. Rizvi, and Manfredi RizzoAnca Pantea StoianAddress correspondence to: Assoc. Prof. Anca Pantea Stoian, MD, PhD, Diabetes, Nutrition and Metabolic Diseases Department, University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Str, 050474, Bucharest, Romania E-mail Address: [email protected]Diabetes, Nutrition and Metabolic Diseases, University of Bucharest, Bucharest, Romania.Search for more papers by this author, Yajnavalka BanerjeeDepartment of Biochemistry, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.Search for more papers by this author, Ali A. RizviDivision of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, Georgia, USA.Search for more papers by this author, and Manfredi RizzoDepartment of Medicine, University of South Carolina, Columbia, South Carolina, USA.Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.Search for more papers by this authorPublished Online:28 Apr 2020https://doi.org/10.1089/met.2020.0037AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookXLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byRole of endothelial cells and angiotensin converting enzyme-II in COVID-19 and brain damages post-infection30 June 2023 | Frontiers in Neurology, Vol. 14COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study27 May 2023 | Microorganisms, Vol. 11, No. 6Incidence and predictors of diabetes mellitus among severe COVID-19 patients in western Ethiopia: a retrospective cohort study22 November 2022 | Journal of Endocrinology, Metabolism and Diabetes of South Africa, Vol. 28, No. 2Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel8 March 2023 | Experimental and Clinical Endocrinology & Diabetes, Vol. 131, No. 05Effect of COVID-19 on Glycemic Control, Insulin Resistance, and pH in Elderly Patients With Type 2 DiabetesCureus, Vol. 71COVID-19: Diabetes Perspective—Pathophysiology and Management25 January 2023 | Pathogens, Vol. 12, No. 2Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study27 December 2022 | Diabetes Therapy, Vol. 14, No. 2Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence26 December 2022 | Metabolites, Vol. 13, No. 1The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal14 February 2022 | Diabetology & Metabolic Syndrome, Vol. 14, No. 1Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug DesignCurrent Pharmaceutical Design, Vol. 28, No. 45Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic healthBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1868, No. 12The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact27 August 2022 | Diabetes Therapy, Vol. 13, No. 10Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert groupInternational Journal of Cardiology, Vol. 365Efficacy and safety of finerenone for treatment of diabetic kidney disease: current knowledge and future perspective6 October 2022 | Expert Opinion on Drug Safety, Vol. 21, No. 9The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus6 August 2022 | Medicina, Vol. 58, No. 8Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment29 July 2022 | Metabolites, Vol. 12, No. 8The Impact of Severe COVID-19 on Plasma Antioxidants21 August 2022 | Molecules, Vol. 27, No. 16Current and emerging drugs for the treatment of atherosclerosis: the evidence to date8 July 2022 | Expert Review of Cardiovascular Therapy, Vol. 20, No. 7Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes4 August 2022 | Expert Review of Clinical Pharmacology, Vol. 15, No. 7Treatment of diabetes and heart failure: Facts and hopesInternational Journal of Cardiology, Vol. 359Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us Anca Pantea Stoian, Peter Kempler, Thomas Stulnig, Ali A. Rizvi, and Manfredi Rizzo18 April 2022 | Metabolic Syndrome and Related Disorders, Vol. 20, No. 3Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment10 March 2022 | Diabetes Therapy, Vol. 13, No. 4Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections25 February 2022 | Expert Opinion on Drug Safety, Vol. 21, No. 3Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study15 February 2022 | Diabetes Therapy, Vol. 13, No. 3Metformin: Sex/Gender Differences in Its Uses and Effects—Narrative Review16 March 2022 | Medicina, Vol. 58, No. 3Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary Artery Disease—State of the Art11 February 2022 | Biology, Vol. 11, No. 2Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL16 February 2022 | Medicina, Vol. 58, No. 2A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies24 January 2022 | Metabolites, Vol. 12, No. 2Correlations between Diabetes Mellitus Self-Care Activities and Glycaemic Control in the Adult Population: A Cross-Sectional Study17 January 2022 | Healthcare, Vol. 10, No. 1Consequences of COVID-19 for the Pancreas13 January 2022 | International Journal of Molecular Sciences, Vol. 23, No. 2Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes11 January 2022 | Medicina, Vol. 58, No. 1The Role of Fructose as a Cardiovascular Risk Factor: An Update12 January 2022 | Metabolites, Vol. 12, No. 1Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel15 December 2021 | Frontiers in Cardiovascular Medicine, Vol. 8Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review26 October 2021 | Diabetes Therapy, Vol. 12, No. 12The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic reviewPrimary Care Diabetes, Vol. 15, No. 6Molecular Endocrinology and Metabolism in 2021: What's New13 December 2021 | International Journal of Molecular Sciences, Vol. 22, No. 24The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism25 August 2021 | Expert Opinion on Drug Safety, Vol. 20, No. 11Narrative review on clinical considerations for patients with diabetes and COVID‐19: More questions than answers21 September 2021 | International Journal of Clinical Practice, Vol. 75, No. 11The Role of Endothelium in COVID-193 November 2021 | International Journal of Molecular Sciences, Vol. 22, No. 21Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues15 November 2021 | International Journal of Molecular Sciences, Vol. 22, No. 22Incretin-based therapies in 2021 – Current status and perspectives for the futureMetabolism, Vol. 122Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies17 September 2021 | International Journal of Molecular Sciences, Vol. 22, No. 18Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective9 September 2021 | Metabolites, Vol. 11, No. 9Implementation and Monitoring of a Telemedicine Model in Acromegalic Outpatients in a Low-Income Country During the COVID-19 Pandemic Luciana Ansaneli Naves, Isabella Naves Rosa, Thomas Alves de Souza Lima, Lidiana Bandeira de Santana, Lucas Faria de Castro, and Luiz Augusto Casulari6 August 2021 | Telemedicine and e-Health, Vol. 27, No. 8Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care6 August 2021 | Medicina, Vol. 57, No. 8COVID-19 in People with Diabetes: Perspectives from Saudi ArabiaCurrent Diabetes Reviews, Vol. 17, No. 6Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection3 June 2021 | Microorganisms, Vol. 9, No. 6Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge1 May 2021 | Journal of Clinical Medicine, Vol. 10, No. 9Diabetes mellitus in combination with COVID-19: modern views on therapy31 March 2021 | REPRODUCTIVE ENDOCRINOLOGY, Vol. 109, No. 57Thrombosis and Haemostasis challenges in COVID-19 – Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions-a mini reviewFood and Chemical Toxicology, Vol. 148Impact of COVID-19 on the Health of Elderly Person21 October 2021Smart Healthcare for Diabetes During COVID-19IEEE Consumer Electronics Magazine, Vol. 10, No. 1Giving Your Electronic Health Record a Checkup After COVID-19: A Practical Framework for Reviewing Clinical Decision Support in Light of the Telemedicine Expansion27 January 2021 | JMIR Medical Informatics, Vol. 9, No. 1Could Dapagliflozin Attenuate COVID-19 Progression in High-Risk Patients With or Without Diabetes? Behind DARE-19 Concept1 July 2021 | Journal of Cardiovascular Pharmacology, Vol. 78, No. 1Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients10 December 2020 | Frontiers in Physiology, Vol. 11TIR-Domain-Containing Adaptor-Inducing Interferon-β (TRIF) Is Involved in Glucose Metabolism in Adipose Tissue through the Insulin/AKT Signaling PathwayInternational Journal of Endocrinology, Vol. 2020The Impact of COVID-19 on Intravitreal Injection Compliance28 October 2020 | SN Comprehensive Clinical Medicine, Vol. 2, No. 12Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study10 December 2020 | Scientific Reports, Vol. 10, No. 1Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease6 July 2020 | Diabetology & Metabolic Syndrome, Vol. 12, No. 1Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes21 November 2020 | International Journal of Clinical Practice, Vol. 21Telemedicine: A promising approach for diabetes management - Where is the evidenceJournal of Diabetes and its ComplicationsIncretin-Based Therapies Role in COVID-19 Era: Evolving Insights3 July 2020 | Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 25, No. 6Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury30 October 2020 | International Journal of Molecular Sciences, Vol. 21, No. 21Diabetes and the COVID-19 Pandemic: What Should the Diabetes Patients Know?30 November 2020 | Pharmaceutical Sciences, Vol. 26, No. Covid-19Diabetes mellitus and COVID-19: current issues of pathogenesis, clinic and therapy. Literature review20 October 2020 | REPRODUCTIVE ENDOCRINOLOGY, Vol. 11, No. 54Diabetes mellitus and COVID-19 in the post-acute phase patients - possible links with physical and rehabilitation medicine and balneotherapy2 September 2020 | Balneo Research Journal, Vol. 11, No. Vol.11, no.3Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapiesDiabetes & Metabolic Syndrome: Clinical Research & Reviews, Vol. 14, No. 5COVID-19 Pandemic: A Threat to a Diabetic PatientThe Open Public Health Journal, Vol. 13, No. 1Knowledge levels among elderly people with Diabetes Mellitus concerning COVID-19: an educational intervention via a teleservice4 August 2020 | Acta DiabetologicaCOVID-19 and diabetes management: What should be considered?Diabetes Research and Clinical Practice, Vol. 163Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence11 May 2020 | Journal of Clinical Medicine, Vol. 9, No. 5Infección por coronavirus en pacientes con diabetesCardiovascular and Metabolic Science, Vol. 31, No. S3Management of diabetes during fasting and COVID-19 – Challenges and solutionsJournal of Family Medicine and Primary Care, Vol. 9, No. 8 Volume 18Issue 4May 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Anca Pantea Stoian, Yajnavalka Banerjee, Ali A. Rizvi, and Manfredi Rizzo.Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.Metabolic Syndrome and Related Disorders.May 2020.173-175.http://doi.org/10.1089/met.2020.0037Published in Volume: 18 Issue 4: April 28, 2020Online Ahead of Print:April 9, 2020 TopicsCOVID-19Diabetes mellitus PDF download
Referência(s)